906 related articles for article (PubMed ID: 11549216)
1. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review.
Geyer MA; Krebs-Thomson K; Braff DL; Swerdlow NR
Psychopharmacology (Berl); 2001 Jul; 156(2-3):117-54. PubMed ID: 11549216
[TBL] [Abstract][Full Text] [Related]
2. Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys.
Linn GS; Negi SS; Gerum SV; Javitt DC
Psychopharmacology (Berl); 2003 Sep; 169(3-4):234-9. PubMed ID: 12845408
[TBL] [Abstract][Full Text] [Related]
3. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients.
Swerdlow NR; Braff DL; Taaid N; Geyer MA
Arch Gen Psychiatry; 1994 Feb; 51(2):139-54. PubMed ID: 8297213
[TBL] [Abstract][Full Text] [Related]
4. Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats.
Barr AM; Powell SB; Markou A; Geyer MA
Neuropharmacology; 2006 Sep; 51(3):457-65. PubMed ID: 16762376
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition.
Semenova S; Geyer MA; Sutcliffe JG; Markou A; Hedlund PB
Biol Psychiatry; 2008 Jan; 63(1):98-105. PubMed ID: 17531208
[TBL] [Abstract][Full Text] [Related]
6. Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs.
Varty GB; Higgins GA
Psychopharmacology (Berl); 1995 Nov; 122(1):15-26. PubMed ID: 8711060
[TBL] [Abstract][Full Text] [Related]
7. Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats.
Swerdlow NR; Bakshi V; Waikar M; Taaid N; Geyer MA
Psychopharmacology (Berl); 1998 Nov; 140(1):75-80. PubMed ID: 9862405
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of antipsychotic and propsychotic drugs on prepulse inhibition and locomotor activity in Roman high- (RHA) and low-avoidance (RLA) rats.
Oliveras I; Sánchez-González A; Sampedro-Viana D; Piludu MA; Río-Alamos C; Giorgi O; Corda MG; Aznar S; González-Maeso J; Gerbolés C; Blázquez G; Cañete T; Tobeña A; Fernández-Teruel A
Psychopharmacology (Berl); 2017 Mar; 234(6):957-975. PubMed ID: 28154892
[TBL] [Abstract][Full Text] [Related]
9. "Early" and "late" effects of sustained haloperidol on apomorphine- and phencyclidine-induced sensorimotor gating deficits.
Martinez ZA; Oostwegel J; Geyer MA; Ellison GD; Swerdlow NR
Neuropsychopharmacology; 2000 Nov; 23(5):517-27. PubMed ID: 11027917
[TBL] [Abstract][Full Text] [Related]
10. Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist.
Bakshi VP; Geyer MA
J Pharmacol Exp Ther; 1997 Nov; 283(2):666-74. PubMed ID: 9353384
[TBL] [Abstract][Full Text] [Related]
11. "Typical" but not "atypical" antipsychotic effects on startle gating deficits in prepubertal rats.
Martinez ZA; Platten A; Pollack E; Shoemaker J; Ro H; Pitcher L; Geyer MA; Swerdlow NR
Psychopharmacology (Berl); 2002 Apr; 161(1):38-46. PubMed ID: 11967629
[TBL] [Abstract][Full Text] [Related]
12. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia.
Swerdlow NR; Geyer MA
Schizophr Bull; 1998; 24(2):285-301. PubMed ID: 9613626
[TBL] [Abstract][Full Text] [Related]
13. Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia.
Swerdlow NR; Geyer MA
Pharmacol Biochem Behav; 1993 Mar; 44(3):741-4. PubMed ID: 8451276
[TBL] [Abstract][Full Text] [Related]
14. Acute or subchronic clozapine treatment does not ameliorate prepulse inhibition (PPI) deficits in CPB-K mice with low levels of hippocampal NMDA receptor density.
Wolf R; Paelchen K; Matzke K; Dobrowolny H; Bogerts B; Schwegler H
Psychopharmacology (Berl); 2007 Sep; 194(1):93-102. PubMed ID: 17541558
[TBL] [Abstract][Full Text] [Related]
15. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.
Braff DL; Geyer MA; Swerdlow NR
Psychopharmacology (Berl); 2001 Jul; 156(2-3):234-58. PubMed ID: 11549226
[TBL] [Abstract][Full Text] [Related]
16. The family of sensorimotor gating disorders: comorbidities or diagnostic overlaps?
Geyer MA
Neurotox Res; 2006 Dec; 10(3-4):211-20. PubMed ID: 17197371
[TBL] [Abstract][Full Text] [Related]
17. Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.
Auclair AL; Kleven MS; Besnard J; Depoortère R; Newman-Tancredi A
Neuropsychopharmacology; 2006 Sep; 31(9):1900-9. PubMed ID: 16421514
[TBL] [Abstract][Full Text] [Related]
18. The 5-HT1A receptor agonist MKC-242 reverses isolation rearing-induced deficits of prepulse inhibition in mice.
Sakaue M; Ago Y; Baba A; Matsuda T
Psychopharmacology (Berl); 2003 Oct; 170(1):73-9. PubMed ID: 12768276
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine.
Bakshi VP; Geyer MA
Psychopharmacology (Berl); 1995 Nov; 122(2):198-201. PubMed ID: 8848537
[TBL] [Abstract][Full Text] [Related]
20. Behavioral studies of hallucinogenic drugs in animals: implications for schizophrenia research.
Geyer MA
Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():73-9. PubMed ID: 9754837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
